The digital health revolution promised to increase access to groundbreaking treatments as it leveled the playing field. However, though biopharma increasingly relies on digital health tools to accelerate innovation, patients are slow to adopt the new tools. Sensors, wearables, and digital therapeutics are frequently inaccessible and unfamiliar to the patients whom such tools are most likely to benefit. Their reluctance further exacerbates health inequities. What means can we use to eliminate infrastructural, institutional, and community-level barriers in order to increase access to, and awareness of, potentially life-enhancing digital health tools? What other barriers to equity need to be demolished, such as lack of access to broadband in under-represented communities? Panelists will discuss the use of digital health technologies and novel tools to address health equity across the R&D ecosystem.

Moderator

Jon Fortt
Co-Anchor, TechCheck, CNBC

Speakers

Irene Dankwa-Mullan
Chief Health Equity Officer, Chief Health Officer, IBM Watson Health

John Doyle
Group Vice President, Exponent

Jennifer Goldsack
CEO, Digital Medicine Society

Lucia Savage
Chief Privacy and Regulatory Officer, Omada Health